Login / Signup

[Possibilities of optimizing therapy in COVID-19 survivors with focal epilepsy].

I V PonomarevaS B StepanovaS A RenevaE V SorokovaM A VaginaO A MakodzebaT R Galiullin
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
The preparation of phenosanic acid can be an effective means of add-on therapy in patients with epilepsy who have undergone COVID-19.
Keyphrases
  • coronavirus disease
  • sars cov
  • young adults
  • respiratory syndrome coronavirus
  • cell therapy
  • mass spectrometry
  • molecularly imprinted
  • replacement therapy
  • chemotherapy induced